Stanabol Tablets
Overview
Stanabol Tablets British Dragon contains stanozolol at 10 mg per tablet — 100 tablets per pack. Stanozolol is a 17α-alkylated DHT-derived anabolic steroid with no estrogenic activity and a strong affinity for sex hormone-binding globulin (SHBG). The 10 mg format provides precise dose control across a 30–50 mg/day range, making it a practical choice for first stanozolol runs and for users stacking it at lower doses alongside injectables. Steroid Warehouse carries the full British Dragon stanozolol lineup: 10 mg oral, 50 mg oral, and 50 mg/ml aqueous suspension.
About the Compound
Stanozolol is a synthetic anabolic steroid derived from dihydrotestosterone (DHT) with a pyrazole ring modification that prevents 5α-reductase conversion and eliminates aromatization. The 17α-alkylation enables oral bioavailability but confers hepatotoxic risk, making it mandatory to run liver support throughout and to cap oral cycles at 8 weeks. The compound binds androgen receptors with moderate affinity and also binds SHBG with unusually high affinity — a mechanism that meaningfully increases circulating free testosterone when stacked with exogenous testosterone.
The 10 mg tablet format in Stanabol BD allows 3–5 tablet daily doses (30–50 mg/day) with easy half-tablet titration, giving more dosing flexibility than the 50 mg format. A 100-tab pack at 30–50 mg/day covers 20–33 days, fitting a 6–8 week cycle with one or two packs depending on the target dose.
What It Does
- SHBG reduction: Stanozolol binds SHBG competitively, displacing testosterone and other steroids from the carrier protein. This increases free testosterone availability — even at modest doses, the SHBG effect meaningfully amplifies the anabolic environment of any testosterone-based stack.
- Lean mass preservation: Stanozolol has anti-catabolic properties that become particularly relevant in a caloric deficit. It supports nitrogen retention and reduces muscle protein breakdown during cutting phases, allowing lean tissue to be preserved while fat is lost.
- Vascularity and muscle hardness: Because stanozolol does not aromatize and causes no water retention, muscle gained or maintained on cycle appears harder and more defined. Subcutaneous water is not added, meaning visible vascularity typically improves — especially at doses of 30–50 mg/day in lean users.
- Strength without proportional mass gain: Stanozolol increases strength disproportionately to its effect on mass. This makes it useful in weight-class sports and for athletes who need performance gains without crossing into a heavier category.
- Androgen receptor activity: The compound binds androgen receptors with moderate affinity and drives anabolic gene expression in muscle tissue, contributing to lean tissue retention and recovery support during high-intensity training blocks.
Who It's For
Stanabol Tablets 10 mg are best suited for users running cutting cycles, body recomposition phases, or pre-contest preparation where the goal is lean mass retention, vascularity, and strength — not bulk or mass. The 10 mg format specifically benefits users who need dose control below 50 mg/day or who are running stanozolol as an add-on alongside an injectable base.
Stanozolol's primary differentiator from other oral cutting agents is its SHBG-reduction mechanism and its unusually clean aesthetic output: no water, no gyno risk, pronounced hardness and definition. Oxandrolone produces similar results at lower androgenic cost but without the SHBG effect, making it the better choice for users prioritizing side-effect minimization or female users. Stanabol 50 Tabs BD is the better option for experienced users who want the convenience of one tablet per day at a full dose.
Users who should choose an alternative: those with existing elevated liver enzymes, poor lipid profiles, or significant genetic hair loss predisposition should consider Oxanabol BD instead. Stanozolol is among the most lipid-toxic oral AAS and accelerates androgenic hair loss in predisposed individuals.
Stanabol Tablets vs Alternatives
| Compound | Key Differences | Choose Stanabol 10 mg When | Choose Alternative When |
|---|---|---|---|
| Stanabol Tabs BD (Stanozolol 10 mg) | 10 mg/tab; flexible daily dosing at 30–50 mg; 100-tab pack; oral 17α-AA; strong SHBG reduction | First stanozolol run; dose titration needed; stacking at lower doses alongside injectables | Full 50 mg/day with no dose adjustments planned — 50 mg tabs are more convenient |
| Stanabol 50 Tabs BD (Stanozolol 50 mg) | 50 mg/tab; 1 tablet = full daily dose; 50-tab pack; same compound and risk profile | Experienced user; fixed 50 mg/day protocol; convenience of single daily tablet | Dose flexibility required; starting below 50 mg/day |
| Stanabol 50 Inj BD (Stanozolol 50 mg/ml) | Aqueous suspension; IM injection; bypasses GI absorption variance; same hepatotoxic risk (17α-AA) | Injectable preference; reduced GI influence on bioavailability; runs alongside injectable AAS | Prefer oral administration; needle aversion |
| Oxanabol Tabs BD (Oxandrolone) | Milder anabolic; lower androgenic activity; less HDL suppression; no SHBG mechanism; female-suitable at low doses | Ultra-mild oral required; hair loss or lipid sensitivity; female users | SHBG reduction and harder cutting effect are priorities; standard-risk male cycle |
Combinations
| Goal | Primary | Support Compounds | Notes |
|---|---|---|---|
| Lean mass / cutting | Stanabol Tabs BD 30–50 mg/day | Testabol Propionate BD | Classic cutting combination; short testosterone ester maintains hormonal baseline without excess water; Stanabol adds hardness and SHBG reduction |
| Pre-contest | Stanabol Tabs BD 50 mg/day | Mastabol 100 BD + Testabol Propionate BD | Pre-contest triple stack: Masteron controls estrogen naturally and adds density, Propionate provides testosterone base, Stanabol drives vascularity and SHBG reduction |
| Strength + oral-only | Stanabol Tabs BD 30 mg/day | Oxanabol BD 30–40 mg/day | Oral-only stack for strength and lean mass; both DHT-based; complementary mechanisms; keep total cycle ≤6 weeks and monitor liver enzymes every 4 weeks |
| Lean mass + longer cycle | Stanabol Tabs BD 30–50 mg/day (last 6–8 weeks) | Testabol Enanthate BD + Anastrozole BD | Add Stanabol as a finishing compound in the final 6–8 weeks of a longer testosterone enanthate cycle; Anastrozole manages any E2 from Enanthate; Stanabol tightens the physique at cycle end |
Side Effects & Management
| Side Effect | Frequency | How to Handle It |
|---|---|---|
| Liver toxicity (ALT / AST elevation) | Very common — all oral 17α-AA | Run liver support throughout: Liv.52 (herbal hepatoprotective, daily), Ursocol / UDCA (300 mg twice daily, reduces cholestatic stress), and Mucinac / NAC (600–1,200 mg/day, supports hepatic glutathione); test ALT/AST every 4 weeks; stop if >3× upper limit |
| HDL suppression / lipid dysregulation | Very common — stanozolol is among the most lipid-toxic AAS | Baseline lipid panel mandatory; monitor every 4 weeks; cardiovascular support with Ecosprin 75 mg/day; post-cycle statin if HDL does not recover within 4–6 weeks: Rosulip or Atorlip |
| Dry joints / arthralgia | Common — no water retention removes synovial cushioning | Reduce dose to the minimum effective level; short-term NSAID: Mobic (meloxicam) for acute joint pain; collagen peptides and glucosamine as adjuncts; fish oil (omega-3) supports joint fluid quality |
| Androgenic hair loss | Common in genetically predisposed users | Finasteride DP (note: stanozolol is already a DHT-derivative and does not convert further via 5α-reductase — finasteride effect is limited; topical approach is more practical); Minoxidil DP topical to support follicle longevity; consider switching to Oxanabol BD for subsequent cycles |
| Acne | Moderate — androgenic stimulation of sebaceous glands | Keep skin clean; Doxycycline 100 mg/day for persistent inflammatory acne; severe/cystic cases: consult isotretinoin only after cycle end and liver enzymes have cleared |
| HPTA suppression | Moderate — LH / FSH suppressed on cycle | Expected during any AAS cycle; run PCT immediately after last dose (see PCT section); confirm LH/FSH recovery via bloodwork 4 weeks post-PCT |
Bloodwork Monitoring
| Lab | When to Test | Target & Action Threshold |
|---|---|---|
| ALT / AST (liver enzymes) | Baseline; every 4 weeks on cycle | <3× ULN; stanozolol is among the most hepatotoxic oral AAS — stop immediately if ALT/AST exceeds 3× upper reference limit; recheck in 2 weeks off cycle |
| HDL cholesterol | Baseline; every 4 weeks | >40 mg/dL; stanozolol severely suppresses HDL — the most critical lipid marker on any stanozolol run; values below 30 mg/dL require cycle interruption |
| LDL cholesterol | Baseline; every 4 weeks | <130 mg/dL; stanozolol raises LDL alongside HDL suppression; address with statin post-cycle if not normalizing |
| Total cholesterol | Baseline; every 4 weeks | <200 mg/dL; HDL:LDL ratio is more informative than total alone on stanozolol |
| Hematocrit / CBC | Baseline; mid-cycle | Hematocrit <52%; stanozolol has mild erythropoietic effect; CBC confirms no unexpected cell-line changes |
| LH + FSH | Baseline; 4 weeks post-PCT | Within normal range post-PCT; confirms HPG axis recovery after stanozolol suppression |
| Total testosterone | Baseline; post-PCT | Return to pre-cycle baseline; suppressed mid-cycle values are expected; recovery is the metric post-PCT |
| Blood pressure | Weekly (first month); monthly thereafter | <130/80 mmHg; stanozolol does not strongly elevate BP, but lipid changes and training intensity can contribute; monitor routinely |
PCT
Stanozolol suppresses LH and FSH moderately through HPG-axis feedback. Post-cycle therapy is required after any stanozolol cycle to restore endogenous testosterone production. Because oral stanozolol has a half-life of approximately 9 hours, it clears the system quickly — PCT can begin within 24–48 hours of the last tablet.
Standard protocol: Clomiphene BD 50 mg/day for weeks 1–2, then 25 mg/day for weeks 3–4; supported by Tamoxifen BD 20 mg/day throughout. For users who ran stanozolol as the sole suppressive compound on a short cycle (6–8 weeks), recovery is typically straightforward with a standard 4-week SERM protocol. Confirm LH/FSH and total testosterone recovery via bloodwork at 4 weeks post-PCT completion.
Practical Summary
- Cycle length — hard cap at 8 weeks: oral 17α-alkylated stanozolol; liver enzyme monitoring every 4 weeks is mandatory; stop immediately if ALT/AST exceeds 3× ULN.
- Dose range: 30–50 mg/day (3–5 tablets); most users find 40–50 mg/day optimal; doses above 50 mg/day increase liver and lipid risk without proportional anabolic benefit.
- Liver support stack — run from day 1: Liv.52 + Ursocol (UDCA) throughout; add Mucinac (NAC) for added hepatic glutathione support.
- Lipid monitoring is non-negotiable: HDL suppression is stanozolol's most significant systemic risk; test every 4 weeks; Ecosprin 75 mg/day as cardiovascular support throughout the cycle.
- Joint pain management: stanozolol removes synovial fluid cushioning; if joint pain develops, reduce dose first; Mobic (meloxicam) short-term for acute pain; omega-3 supplementation throughout.
- PCT timing: begin Clomiphene BD + Tamoxifen BD within 24–48 hours of last tablet; stanozolol clears quickly; 4-week standard SERM protocol is sufficient for most users.
Stanabol Tablets British Dragon delivers the practical advantages of 10 mg stanozolol tablets — precise dose flexibility, a 100-tablet supply suited to a full 6–8 week cycle, and a well-established DHT-based profile for lean mass and cutting. The 10 mg format is the default choice for users calibrating dose on a first stanozolol run or stacking it at lower doses alongside injectables. Liver and lipid management are non-negotiable for any oral stanozolol protocol. For users at steroidwarehouse.com who prioritize lean, dry gains without water retention or estrogenic activity, the 10 mg tablet format remains one of the most dependable stanozolol options in the British Dragon lineup.
References
| Source | Topic | Link |
|---|---|---|
| New England Journal of Medicine / PubMed | Bhasin et al. 1996 — randomized controlled trial evaluating 600 mg/week testosterone enanthate in healthy men with and without resistance training; demonstrated significant increases in fat-free mass, muscle size, and strength, establishing the anabolic effects of supraphysiologic testosterone administration | Bhasin S, et al. (1996) ↗ |
| NCBI Bookshelf / StatPearls | Anabolic steroids overview — clinical reference on synthetic testosterone-derived anabolic-androgenic steroids, androgen receptor activity, oral and injectable forms, adverse effect profiles, misuse patterns, and monitoring considerations | StatPearls: Anabolic Steroids ↗ |
| NCBI Bookshelf / Endotext | Androgen physiology and pharmacology — comprehensive overview of testosterone, dihydrotestosterone, androgen receptor signaling, HPG-axis regulation, synthetic androgen pharmacology, aromatization, and endocrine suppression associated with exogenous androgen use | Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗ |
| JAMA / PubMed | Thompson PD et al. 1989 — study comparing the effects of testosterone and stanozolol on serum lipoprotein levels; reported increased LDL cholesterol and marked HDL suppression with stanozolol, supporting its unfavorable lipid-profile effects | Thompson PD, et al. (1989) ↗ |
| Sports Medicine / PubMed | Hartgens F & Kuipers H 2004 — review of androgenic-anabolic steroid effects in athletes; covers body composition, strength, lipid profiles, cardiovascular effects, endocrine suppression, hepatic effects, and psychological considerations across multiple anabolic-androgenic steroids | Hartgens F & Kuipers H (2004) ↗ |
What is Stanabol Tablets?
Stanabol Tablets are an oral anabolic steroid (Stanozolol) for lean muscle and definition; see What is Stanabol Tablets. It's effective—consult professionals for safe use.
What does Stanabol do?
It promotes lean muscle, strength, and fat loss; see What Does Stanabol Do. It enhances definition—monitor with labs.
Are Stanabol Tablets safe?
They can be safe with responsible use and monitoring, but risks include liver strain and cholesterol changes; see Are Stanabol Tablets Safe. Consult professionals for oversight.
How do I take Stanabol?
20-50 mg/day for men, 5-10 mg/day for women, split daily or twice daily; see How to Take Stanabol. Start low—consult professionals for dosing.
How long does it take to notice effects from Stanabol Tablets?
As an oral compound, users often report gradual improvements in strength, muscle hardness, vascularity, and overall physique appearance within several weeks of consistent use.
What are the main benefits of Stanabol Tablets?
Commonly reported benefits include enhanced muscle definition, increased strength, improved vascularity, support for lean muscle retention, and a dry, aesthetic physique appearance.
Are Stanabol Tablets better for bulking or cutting?
Stanabol Tablets are most commonly associated with cutting and recomposition phases due to their reputation for promoting a lean, hard, and defined physique with minimal water retention.
What makes Stanabol Tablets different from other oral anabolic steroids?
Stanabol Tablets are known for their association with muscle hardness, definition, and physique refinement rather than significant increases in body weight or water retention.
Related Products
